Sante Mernaud Pharmaceuticals Private Limited, a active private limited company, was established on 26 June 2006 in Bangalore, Karnataka, India. Engaging in personal care & skincare products within the manufacturing sector, it holds CIN: U24239KA2006PTC039813. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.38 Cr.
It upholds a active non-compliant status. Its leadership includes Motilal Heeralal Doddamani (Whole-Time Director), Kalennahalli Siddalingaiah Jagadesha (Director), Amogh S Hiremath (Director). Past directors included Shivabal Ramachandra Khokate, Shashikala Annasaheb Jolle, Padubidre Sakharama Prabhu. It holds ₹1.37 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at No.466 12Th A Cross Peenya 4Th Phase Peenya Industrial Area Peenya, Bangalore, Karnataka, 560058.
U24239KA2006PTC039813
039813
26 June 2006
₹1.50 Cr
₹1.38 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sante Mernaud Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Motilal Heeralal Doddamani | Whole-Time Director | 01 Mar 2012 | Current |
| Kalennahalli Siddalingaiah Jagadesha | Director | 10 May 2021 | Current |
| Amogh S Hiremath | Director | 19 Dec 2020 | Current |
| Shoba Hiremath | Director | 26 Jun 2006 | Current |
| Shivabasavesh Prabhudevayya Hiremath | Director | 26 Jun 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 03 Sep 2013 | Past |
| Pramod Abcsdd | Director | 14 Sep 2012 | Past |
| Pramod Abcsdd | Director | 04 Sep 2013 | Past |
| Pramod Abcsdd | Director | 31 Dec 2012 | Past |
| Pramod Abcsdd | Director | 14 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sante Mernaud Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.58% increase. The company also saw a substantial improvement in profitability, with a 76.46% increase in profit. The company's net worth moved up by a moderate rise of 0.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sante Mernaud Pharmaceuticals had a promoter holding of 73.26% and a public holding of 26.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,650,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2007 | Canara Bank | ₹0.65 M | Open |
| 21 Mar 2007 | Canara Bank | ₹1.30 Cr | Open |
Explore comprehensive loan charge details -
Sante Mernaud Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sante Mernaud Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sante Mernaud Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sante Mernaud Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was completed.
Progress on Sante Mernaud Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Kalennahalli Siddalingaiah Jagadesha was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
Progress on Amogh S Hiremath was appointed as a Director was appointed as a Director on 19 Dec 2020 & has been associated with this company since 5 years 29 days . was documented.
Progress on A charge with Canara Bank of Rs. 1.30 Cr registered on 21 Mar 2007 with Charge ID 10050022 was modified on 08 Dec 2016. was documented.
Progress on Motilal Heeralal Doddamani was appointed as a Whole-time director was appointed as a Whole-time director on 01 Mar 2012 & has been associated with this company since 13 years 10 months . was documented.
The CIN of Sante Mernaud Pharmaceuticals Private Limited is U24239KA2006PTC039813.
Sante Mernaud Pharmaceuticals Private Limited is headquartered at No.466 12Th A Cross Peenya 4Th Phase Peenya Industrial Area Peenya, Bangalore, Karnataka, 560058.
Sante Mernaud Pharmaceuticals Private Limited was incorporated on 26 June 2006.
The current directors of Sante Mernaud Pharmaceuticals Private Limited are
The primary industry of Sante Mernaud Pharmaceuticals Private Limited is Manufacturing.
Sante Mernaud Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sante Mernaud Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.38 Cr.
The compliance status of Sante Mernaud Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX